Tag: Hematologic disorders

Drug-induced immune thrombocytopenia (DITP) is a known adverse reaction to over 300 medications [1.7.1]. While rare, with an incidence of less than 1%, postmarketing reports and case studies confirm that **can diltiazem cause thrombocytopenia** through an immune-mediated process [1.3.5, 1.6.1].

Nearly all chemotherapy agents cause a reduction of blood cell counts, a process known as bone marrow suppression. Beyond chemotherapy, a variety of medications, from common antibiotics to powerful immunosuppressants, can adversely affect the bone marrow, the body's factory for blood cells. Recognizing which medications affect bone marrow is crucial for patient safety and effective clinical management.

While thrombocytopenia is a very rare adverse effect of spironolactone, with an incidence of less than 0.1%, healthcare professionals and patients should be aware of this potential hematologic risk. Individual case reports have documented severe instances, particularly in patients with pre-existing conditions like liver cirrhosis.